Selectis Health extends $1.775M notes to Feb 2026, interest rate raised to 13%

SELECTIS HEALTH, INC.

Maturity extended to Feb 28, 2026 or earlier upon Qualified Transaction; 30-day extensions possible with 0.5% fee.
Interest rate increased from 11% to 13% per annum effective Jan 1, 2026.
Warrants extended to Dec 31, 2027; exercise price unchanged at $2.25 per share.
Kent Lund and Lance Baller appointed to Board of Directors effective Jan 1, 2026.
Solicitation fee of $9,000 paid to GVC Capital LLC in connection with the amendment.

item 2.03item 3.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.